We are truly honored to be featured by Dr. Matthias Mann at the HUPO plenary session. We deeply appreciate the recognition of our work in building a labeled heavy human proteome. Visit us at booth 29 for more in-depth conversations about the future of proteomics. #HUPO2024 #Proteomics #Absea #HumanProteome
Info
Absea is a transformative force in the protein engineering industry. Established in 2020, we are one of the fastest-growing biotech companies with currently over 250 employees across the globe. Our cutting-edge platform for developing soluble proteins and monoclonal antibodies offers unparalleled throughput, enabling up to 1000 new development projects per month. Through dynamic collaborations with leaders in the life sciences, especially in proteomics, we have built a library of 12,000 soluble proteins covering 60% of the human proteome and we continue to broaden our synthetic proteome portfolio. Our monoclonal antibodies, validated for diverse applications, stand ready for widespread supply to the general market. Beyond this, we offer cutting-edge technological solution for proteomics and interactomics. From our Innovation Center in Berlin, Manufacturing Centers in China, and Commercialization Center in the Bay Area, we cater to the needs of protein scientists as well as industry partners active in AI-driven protein design, diagnostics, and drug development. We strive to become a long-term partner for the world's leading labs, companies and service providers.
- Website
-
http://www.absea.bio
Externer Link zu Absea Biotech
- Branche
- Biotechnologieforschung
- Größe
- 201–500 Beschäftigte
- Hauptsitz
- Berlin
- Art
- Privatunternehmen
- Gegründet
- 2020
- Spezialgebiete
- monoclonal antibody, protein, proteomics, CRO und reagent
Orte
-
Primär
Absea Biotechnology GmbH, Building D85, Robert-Roessle-Str. 10
Berlin, 13125, DE
Beschäftigte von Absea Biotech
-
Marnix Bos
SEA specialist at Youvia
-
Joy Zhou
Market Director | Biotech Innovator | Antibodies, Proteins, and Beyond | Shanghai-Based | SJTU & UIUC Alum
-
Fan Liu
Principle investigator at Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP); Professor at Charité - Universitätsmedizin; Scientific…
-
Aziz sumbhaniya
yacht captain at absea
Updates
-
We’re excited to be attending #HUPO2024 in Dresden! 🎉 Come visit us at Booth 29 to explore Absea’s cutting-edge proteomics solutions. Whether you’re looking for the latest innovations in proteins and antibodies or just want to connect, we’d love to meet you and discuss how we can support your research. See you at #HUPO2024! #Proteomics #Antibodies #Proteins #ResearchInnovation #Dresden #HUPO
-
Had a fantastic time at Westlake University , meeting with Dr. Tiannan Guo and his team. We discussed our research, explored potential collaborations, and got a deep dive into their impressive work. "Passionate at heart, visionary in sight. Essence in genes, destiny in proteins."
-
Super exciting postoc opportunity for MS researchers and biochemists in the lab of our principal scientific advisor Fan Liu!
Principle investigator at Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP); Professor at Charité - Universitätsmedizin; Scientific Advisor at Absea Biotechnology; Scentific Advisor at VantAI
!!!JOB ALERT!!! My lab has several great openings for postdocs and staff scientists - both academic and joint with industry. We need: protein mass spec expertise We offer: cutting-edge infrastructure, great working environment, and competitive salary! We also have opportunities for biochemists, bioinformaticians and cell biologists in the area of structural Interactomics and cross-linking mass spectrometry. Want to know more? Check out our interests and papers at www.theliulab.com and get in touch via https://lnkd.in/e84JNuJ9
-
Congrats to Maria Wahle and all coworkers from Matthias Mann lab and Thermo Fisher Scientific on this hot-off-the-press preprint introducing the new #Orbitrap Stellar mass spectrometer and featuring Absea’s 15N heavy isotope-labeled proteins. We’re very proud to see how our 15N-labeled standards bring us closer to mass spec-based clinical testing of protein biomarkets! https://lnkd.in/dBxTyXYN
A novel hybrid high speed mass spectrometer allows rapid translation from biomarker candidates to targeted clinical tests using 15N labeled proteins
biorxiv.org
-
We’re getting ready for #ASMS! Come visit us to learn more about our proteome-scale protein and antibody libraries and customized development services.
-
Absea Biotech hat dies direkt geteilt
👏 In the last month Prof. Dr. Fan Liu has been honored with multiple awards recognizing her significant contributions to cross-linking mass spectrometry. Her work is focused on elucidating protein interactions within cells. Read more about her work: https://lnkd.in/detW6xXC Photo: Jürgen Gross
The Protein Expert
leibniz-fmp.de
-
Absea Biotech hat dies direkt geteilt
👏 In the last month Prof. Dr. Fan Liu has been honored with multiple awards recognizing her significant contributions to cross-linking mass spectrometry. Her work is focused on elucidating protein interactions within cells. Read more about her work: https://lnkd.in/detW6xXC Photo: Jürgen Gross
The Protein Expert
leibniz-fmp.de
-
Absea Biotech hat dies direkt geteilt
Principle investigator at Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP); Professor at Charité - Universitätsmedizin; Scientific Advisor at Absea Biotechnology; Scentific Advisor at VantAI
Mattauch-Herzog award ceremony part II: A big thank you to Alexander Makarov and Rosy Lee for handing over the plaque! It is truly delightful to work with Thermo Fisher and I very much look forward to many more collaborations in the future!
-
Absea Biotech hat dies direkt geteilt
2024 Wisconsin Human Proteomics Symposium "New Frontiers in Clinical Proteomics " July 31 -- August 1, 2024, Madison, WI https://lnkd.in/drFGYxq4 Please save the date! Registration will open soon! Many thanks to our speakers and sponsors! PROGRAM The University of Wisconsin (UW)-Madison School of Medicine and Public Health (SMPH) Human Proteomics Program (HPP) and UW Institute for Clinical and Translational Research (ICTR) are pleased to offer this excellent symposium! The theme of this year's exciting program is New Frontiers in Clinical Proteomics. Clinical Proteomics is a burgeoning interdisciplinary research domain that brings together researchers from diverse biomedical fields, offering a promising avenue for translating fundamental scientific insights into practical clinical applications to improve patient outcomes. This year's exciting program features 2 keynote presentations and 12 invited oral presentations from internationally recognized leaders in Clinical Proteomics. Poster and exhibitor sessions will occur between and following oral sessions. There will also be a rising star session to promote young scientists and a workshop dedicated to women's initiatives and DEI to support and promote women scientists and diversity. Meeting attendees are encouraged to present their recent work in scientific poster sessions. A poster contest open to graduate students and post-doctoral researchers is included. Based on prior symposium participation, we anticipate 200-300 conferees with up to 100 posters from academia, clinics, and industry with many opportunities for discussion and intermingling. Many thanks to our sponsors for their generous sponsorship! Diamond sponsorship: Promega Corporation (Atul D. Frank Fan) Bruker Daltonics (Paul Speir Michael Greig) Thermo Fisher Scientific (Vlad Zabrouskov Shen Luan); Absea Biotech (Tao Chen, Philip Lössl) Silver sponsorship: Waters Corporation (Noah Iskandarani Yuriy Pyatkivskyy); SCIEX (David Colquhoun Randy Arnold) Bronze and lunch seminar sponsorship: Agilent Technologies (John Sausen Jonathan Osborn)! Bronze Sponsorship: Avantor (Kristin Pagel)!